Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ad66884a6f2a66126d492e56e09be39 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
filingDate |
1972-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1974-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aee7736c577cc82ab310abd6931d6b9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ebe28bb00c50248a0f586134ec1a55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27b8d0a499298bbaaa81ba417e7d807 |
publicationDate |
1974-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-3812258-A |
titleOfInvention |
Pharmaceutical composition essentially containing and method of treatment with,3 beta-acetoxy 11-oxo noroleanene-(12) 20 beta-carboxylic acid n-methyl piperidol-(4) ester |
abstract |
3-B-Acetoxy 11-oxo noroleanene-(12) 20B-carboxylic acid N-methyl piperidol-(4) ester and physiologically tolerable acid addition salts thereof that are orally administerable and have superior inflammation inhibiting and ulcer inhibiting properties. |
priorityDate |
1970-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |